Novo Nordisk's Chief Scientific Officer said: We believe the new generation GLP-1 may have differentiated advantages in efficacy, convenience, safety and tolerability.

Zhitongcaijing · 3d ago
Novo Nordisk's Chief Scientific Officer said: We believe the new generation GLP-1 may have differentiated advantages in efficacy, convenience, safety and tolerability.